[ Price : $8.95]
Federal Register notice: FDA clarifies that despite enforcement discretion efforts during the Covid-19 pandemic, Class 1 surgeon a...[ Price : $8.95]
FDA approves Bristol-Myers Squibbs Opdivo (nivolumab) for combination use with chemotherapy for the initial treatment of patients ...[ Price : $8.95]
Becton Dickinson recalls (Class 1) its CareFusion 303 Alaris Pump Module because of the risk of the keypad lifting up due to fluid...[ Price : $8.95]
Eli Lilly asks FDA to revoke its Emergency Use Authorization for bamlanivimab (LY-CoV555) 700 mg alone due to the growing prevalen...[ Price : $8.95]
FDA grants Perimeter Medical Imaging AI a breakthrough device designation for its Optical Coherence Tomography Imaging System coup...[ Price : $8.95]
Federal Register notice: FDA announces a 6/7-8 public workshop entitled Morphine Milligram Equivalents: Current Applications and K...[ Price : $8.95]
CDRH says its response to the significant Covid-19 workload has led to delays in other product reviews.[ Price : $8.95]
Harvard University professors say FDA could use a change in the GDUFA fee structure to increase generic drug competition.